Hikma Pharmaceuticals Plc Company Profile (LON:HIK)

Analyst Ratings

Consensus Ratings for Hikma Pharmaceuticals Plc (LON:HIK) (?)
Ratings Breakdown: 2 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: GBX 2,605.90

Analysts' Ratings History for Hikma Pharmaceuticals Plc (LON:HIK)
Show:
DateFirmActionRatingPrice TargetActions
7/26/2016Jefferies GroupBoost Price TargetBuyGBX 2,800 -> GBX 2,990View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2016Numis Securities LtdInitiated CoverageAddGBX 2,830View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2016Morgan StanleyInitiated CoverageEqual weightGBX 2,700View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2016Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 2,300View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016Barclays PLCBoost Price TargetOverweightGBX 2,760 -> GBX 2,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016HSBCReiterated RatingBuyGBX 2,525View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Panmure GordonUpgradeBuyGBX 2,120View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016AlphaValueReiterated RatingBuyGBX 2,554View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Shore CapitalUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Beaufort SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Hikma Pharmaceuticals Plc (LON:HIK)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Hikma Pharmaceuticals Plc (LON:HIK)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Hikma Pharmaceuticals Plc (LON:HIK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
3/11/2015GBX 0.210.64%4/16/20154/16/20155/21/2015Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Hikma Pharmaceuticals Plc (LON:HIK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/24/2016Darwazah,MazenInsiderBuy150,000GBX 2,200£3,300,000Tweet This Trade  Share This Trade on StockTwits
6/17/2016Al-Husry,AliInsiderBuy70,000GBX 22£15,400Tweet This Trade  Share This Trade on StockTwits
5/9/2016Darwazah,SaidInsiderBuy17,440GBX 2,228£388,563.20Tweet This Trade  Share This Trade on StockTwits
4/26/2016Darwazah,SaidInsiderBuy10,000GBX 2,260£226,000Tweet This Trade  Share This Trade on StockTwits
4/25/2016Darwazah,SaidInsiderBuy10,000GBX 2,324£232,400Tweet This Trade  Share This Trade on StockTwits
4/22/2016Darwazah,SaidInsiderBuy30,000GBX 2,325£697,500Tweet This Trade  Share This Trade on StockTwits
4/20/2016Darwazah,SaidInsiderBuy30,000GBX 2,271£681,300Tweet This Trade  Share This Trade on StockTwits
4/19/2016Darwazah,SaidInsiderBuy30,000GBX 2,266£679,800Tweet This Trade  Share This Trade on StockTwits
4/11/2016J. Castellani,JohnInsiderBuy2,500GBX 2,103£52,575Tweet This Trade  Share This Trade on StockTwits
4/7/2016Darwazah,MazenInsiderBuy60,000GBX 2,118£1,270,800Tweet This Trade  Share This Trade on StockTwits
4/5/2016Darwazah,SaidInsiderBuy30,000GBX 2,055£616,500Tweet This Trade  Share This Trade on StockTwits
3/31/2016Darwazah,SaidInsiderBuy30,000GBX 1,972£591,600Tweet This Trade  Share This Trade on StockTwits
3/24/2016Butler,PatInsiderBuy2,500GBX 1,920£48,000Tweet This Trade  Share This Trade on StockTwits
3/21/2016Pickering ,RobertInsiderBuy2,500GBX 1,856£46,400Tweet This Trade  Share This Trade on StockTwits
8/27/2015Kirby,PamelaInsiderBuy3,317GBX 2,264£75,096.88Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Hikma Pharmaceuticals Plc (LON:HIK)
DateHeadline
07/27/16 04:39 PMU.K. shares higher at close of trade; Investing.com United Kingdom ... - Investing.com UK
07/27/16 07:12 AMJefferies International reiterated Hikma Pharmaceuticals PLC (LON ... - FTSE News
07/26/16 04:39 PMBrokers: Deutsche downgrades housebuilders - Proactive Investors UK
07/26/16 07:21 AMBrokers: Deutsche positive on housebuilders despite downgrades - Proactive Investors UK
07/26/16 07:21 AMHikma Pharmaceuticals Plc 15.6% Potential Upside Indicated by Jefferies International - DirectorsTalk Interviews
07/26/16 03:48 AMRegulatory approval of Hikma’s colchicine is upheld - [at noodls] - London, 21 July 2016 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, today ...
07/25/16 09:02 AMHikma Pharmaceuticals : *JPMORGAN RAISES HIKMA PHARMACEUTICAL TARGET TO 2800 PENCE - 'OVERWEIGHT'
07/23/16 04:11 PMUK stocks higher at close of trade; Investing.com United Kingdom 100 up 0.47% - Investing.com
07/23/16 04:11 PMNumis Securities Gives Hikma Pharmaceuticals PLC Price Target With Potential 9.86% Upside - FTSE News
07/22/16 04:22 PMHikma Pharmaceuticals : Morgan Stanley Begins Coverage on Hikma Pharmaceuticals Plc (HIK)
07/22/16 03:10 PMHikma Pharmaceuticals Plc : Undervalued relative to peers, but don’t ignore the other factors -
07/21/16 04:35 PMHikma Reports Court Approval To Continue Marketing Colchicine Products In U.S.
07/21/16 04:35 PMHikma Pharmaceuticals : Regulatory Approval Of Hikma's Colchicine Capsule Upheld By US Court
07/21/16 04:35 PMA report released today by Morgan Stanley about (LON:HIK) Hikma Pharmaceuticals PLC raises the target price to 2,700GBX
07/21/16 10:27 AMHikma reports Court approval to continue marketing colchicine products in U.S. - RTT News
07/21/16 10:27 AMBRIEF-Hikma says US Court of Appeals upholds regulatory approval of colchicine - Reuters
07/20/16 08:45 PMWest-Ward Pharmaceuticals launches capecitabine tablets
07/20/16 08:45 PMHikma Launches Generic Xeloda Tablets 150 Mg And 500 Mg In U.S.
07/20/16 08:45 PMTOP NEWS: Hikma Pharmaceuticals Launches Xeloda Tablets In US
07/20/16 08:45 PMHikma launches generic Xeloda tablets in U.S.
07/20/16 07:23 AMHikma launches generic Xeloda tablets in US - MarketWatch
07/20/16 07:23 AMBRIEF-Hikma Pharma announces US launch of two generic tablets - Reuters
07/20/16 04:16 AMFTSE rallies though miners lag - [Reuters] - By Kit Rees LONDON (Reuters) - UK shares advanced on Wednesday, supported by recent currency weakness and gains in healthcare stocks, though miners fell after updates from Anglo American (AAL.L) and BHP ...
07/15/16 07:37 AMWere Analysts Bullish Hikma Pharmaceuticals Plc (LON:HIK) This Week? - Consumer Eagle
07/15/16 01:10 AMIs it too late to buy rapid risers ARM Holdings plc, WPP plc ord 10p and Hikma Pharmaceuticals plc? -
07/13/16 07:21 AMUK shares higher at close of trade; Investing.com United Kingdom 100 up 0.04% - Investing.com UK
07/13/16 07:21 AMHikma Pharmaceuticals Plc Stock Is Crashing Now - Consumer Eagle
07/07/16 07:19 AMHikma Pharmaceuticals PLC (LON:HIK) Issued With 'Buy' Rating At Jefferies & Co - FTSE News
07/06/16 04:38 PMJefferies International Gives Hikma Pharmaceuticals PLC Price Target With Potential 12.49% Upside - FTSE News
07/05/16 04:19 PMJefferies covered (LON:HIK) Hikma Pharmaceuticals, stepping up its price target to GBX2,800 earlier today
07/05/16 04:45 AM3 Brexit-resistant shares -
07/01/16 04:27 PMLyon manufacturing facility returns to the Vectura Group - PharmiWeb.com (press release)
06/30/16 04:42 PMHikma Pharmaceuticals (LON:HIK) New Price Targets - FTSE News
06/29/16 07:21 PMHikma Pharmaceuticals to participate in The World Economic Forum’s Industry Strategy Meeting - [at noodls] - Hikma Pharmaceuticals to participate in The World Economic Forum's Industry Strategy Meeting Amman, June 2016 - Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's ...
06/29/16 04:24 PMHikma Pharmaceuticals : to participate in The World Economic Forum's Industry Strategy Meeting
06/29/16 03:28 AMEuropean healthcare first sector to recover Brexit losses - [Reuters] - The rush to large-cap, high quality, dividend-paying pharmaceutical stocks in the aftermath of Brexit has helped Europe's healthcare index erase all its losses since last week's vote. The healthcare index, up 1.4 percent on Wednesday, is the only regional sector index to trade above last Thursday's close.
06/27/16 08:49 AMHikma Pharmaceuticals : acquires six injectable products in Europe
06/27/16 03:46 AMHikma Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : HIK-GB : June 27, 2016 -
06/26/16 03:53 PMEarnings are set to sink at Burberry Group plc, Hikma Pharmaceuticals plc and J Sainsbury plc! Should you buy? - Motley Fool UK
06/24/16 10:54 AMHikma Pharmaceuticals PLC (LON:HIK) stock price target held steady to GBX0 as recorded today by Stifel
06/24/16 03:10 AMHikma acquires six injectable products in Europe - [at noodls] - London, 24 June 2016 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announces ...
06/23/16 07:21 AMRoyal Jordanian : Said Darwazeh elected RJ Chairman of the Board of Directors; Suleiman Obeidat appointed a board member
06/23/16 07:21 AMSaid Darwazeh elected RJ chairman of the board of directors
06/22/16 04:33 PMRJ elects Darwazeh as chairman of Board of Directors
06/20/16 04:13 PMShould you buy or sell Majestic Wines plc, Enquest plc and Hikma Pharmaceuticals plc after today's news? - Yahoo Finance UK
06/20/16 02:34 PMHikma Pharmaceuticals Plc – Value Analysis (LONDON:HIK) : June 20, 2016 -
06/18/16 08:51 AMNewly released market study: Schistosomiasis Global Clinical Trials Review, H1, 2016
06/15/16 04:29 PMUK stocks higher at close of trade; Investing.com United Kingdom 100 up 0.78% - Investing.com
06/14/16 03:50 AMHikma Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : HIK-GB : June 14, 2016 -
06/13/16 11:49 AMHikma receives FDA approval for Letrozole Tablets - [at noodls] - London, 13 June 2016 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announces ...

Social

About Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc logoHikma Pharmaceuticals PLC is a pharmaceutical company engaged the development, manufacture and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms. The Company is focused on therapeutic areas, such as oncology, diabetes and cardiovascular and central nervous system (CNS). The Company's operations are conducted through three business segments: Branded, Injectables and Generics. Its Branded business manufactures and markets generic and in-licensed originator products across the Middle East and North Africa (MENA) region. Its Injectables business manufactures and markets branded and non-branded generic injectable products in the United States, Europe and MENA. Its Generics business manufactures non-branded oral generic products for sale in the United States market. It operates primarily in the MENA region, the United States and Europe.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: HIK
  • CUSIP:
Key Metrics:
  • Previous Close: $33.96
  • 50 Day Moving Average: $2409.68
  • 200 Day Moving Average: $2149.33
  • P/E Ratio: 21.00
  • P/E Growth: 1.36
  • Market Cap: $5.25B
  • Current Year EPS Consensus Estimate: $1.17 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: